Szczurek-Wasilewicz, W.; Skrzypek, M.; Romuk, E.; Gąsior, M.; Szyguła-Jurkiewicz, B.
The Utility of Pentraxin and Modified Prognostic Scales in Predicting Outcomes of Patients with End-Stage Heart Failure. J. Clin. Med. 2022, 11, 2567.
https://doi.org/10.3390/jcm11092567
AMA Style
Szczurek-Wasilewicz W, Skrzypek M, Romuk E, Gąsior M, Szyguła-Jurkiewicz B.
The Utility of Pentraxin and Modified Prognostic Scales in Predicting Outcomes of Patients with End-Stage Heart Failure. Journal of Clinical Medicine. 2022; 11(9):2567.
https://doi.org/10.3390/jcm11092567
Chicago/Turabian Style
Szczurek-Wasilewicz, Wioletta, Michał Skrzypek, Ewa Romuk, Mariusz Gąsior, and Bożena Szyguła-Jurkiewicz.
2022. "The Utility of Pentraxin and Modified Prognostic Scales in Predicting Outcomes of Patients with End-Stage Heart Failure" Journal of Clinical Medicine 11, no. 9: 2567.
https://doi.org/10.3390/jcm11092567
APA Style
Szczurek-Wasilewicz, W., Skrzypek, M., Romuk, E., Gąsior, M., & Szyguła-Jurkiewicz, B.
(2022). The Utility of Pentraxin and Modified Prognostic Scales in Predicting Outcomes of Patients with End-Stage Heart Failure. Journal of Clinical Medicine, 11(9), 2567.
https://doi.org/10.3390/jcm11092567